Ariad Pharmaceuticals Inc fka ARIA

[zuize]

Actually there are "only" 21 VPs at Ariad + Dr. HB = 22.
Below is the 21 VPs listed as "Vice President" I took directly from Ariad website: http://www.ariad.com/company_leadership

Harvey J. Berger, M.D.
Chairman and Chief Executive Officer
1. David L. Berstein, Esq.
Senior Vice President, General Counsel and Chief Intellectual Property Counsel
2. Daniel M. Bollag, Ph.D.
Senior Vice President of Regulatory Affairs and Quality
3. Maria E. Cantor
Senior Vice President, Corporate Affairs and Human Resources
4. Timothy P. Clackson, Ph.D.
President of Research and Development and Chief Scientific Officer
5. Hugh M. Cole
Senior Vice President and Chief Business Officer
6. Martin J. Duvall
Executive Vice President and Chief Commercial Officer
7. Edward M. Fitzgerald
Executive Vice President, Chief Financial Officer and Treasurer
8. Frank G. Haluska, M.D., Ph.D.
Chief Medical Officer and Senior Vice President, Clinical R&D
9. Joseph Bratica
Vice President, Finance and Controller
10. David C. Dalgarno, Ph.D.
Vice President, Research Technologies
11. Jonathan E. Dickinson
Vice President, European Operations and General Manager, ARIAD Pharmaceuticals (Europe), Sarl
12. Shirish Hirani, Ph.D.
Vice President, Drug Development
13. Lori Horvat
Vice President, Marketing
14. Stephen R. Jamieson
Vice President of Information Technology
15. Ronald K. Knickerbocker, Ph.D.
Vice President, Biomedical Data Sciences and Information
16. Timothy Maines
Vice President, Quality
17. Yan Moore, M.D.
Vice President, Medical Affairs
18. Christopher K. Murray, Ph.D.
Vice President, Technical Operations
19. Victor M. Rivera, Ph.D.
Vice President, Preclinical and Translational Research
20. William C. Shakespeare, Ph.D.
Vice President, Drug Discovery
21. Piet A.M Vervaet, M.D.
Vice President, Drug Safety and Pharmacovigilance

Per the jobs title, it's obvious some are overlapped and redundant and really need only 1 VP for handling the tasks. For example, #2, #16, and #21. There should be only 1 VP for managing quality control and drug safety. Or #5 and #6, Or #7 and #9: with a size of ~200 employees, do they really need 2 VPs for handling finance?